Concerns that well-funded Chinese companies will swoop in to grab new ideas for their own drug development are shaping an industry unaccustomed to such secrecy.
This post first appeared in The New York Times – Business. Read the original article.Fearing Chinese Rivals, U.S. Biotech Adopts a New Norm: Share Nothing
The New York Times – Business:

Leave a Reply